Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the Tribunal could dispose of the assessee's appeal without first deciding the classification of the products as patent or proprietary medicaments or generic medicaments, and the consequential eligibility to Modvat credit.
Analysis: The dispute turned on whether the products fell under Chapter 30 Sub Heading 3003.10 or Sub Heading 3003.20 of the Central Excise Tariff Act, 1985, because the classification determined whether the final products attracted duty or Nil rate of duty and, in turn, whether Modvat credit on inputs was admissible. The Tribunal had allowed the appeal by relying on earlier orders without examining the core classification controversy raised in the show cause notice, the adjudication order, and the first appellate order. As the last fact-finding authority, the Tribunal was required to address the foundational issue before deciding the credit issue.
Conclusion: The Tribunal's order was held to be unsustainable for failure to decide the basic classification issue and the connected Modvat credit question.
Final Conclusion: The impugned orders were set aside and the matter was restored to the Tribunal for decision on all grounds afresh, with all contentions kept open.
Ratio Decidendi: A final fact-finding authority must decide the foundational classification issue before ruling on consequential credit entitlement, and an order that omits such core adjudication cannot stand.